We are live on
!
Find out more
VCG
Vantage Consulting Group Portfolio holdings
AUM
$19.7M
1-Year Est. Return
280.87%
This Fund
S&P 500
This Quarter
Est. Return
+17.65%
1 Year Est. Return
+280.87%
3 Year Est. Return
+261.08%
5 Year Est. Return
+180.34%
10 Year Est. Return
–
AUM
$1.23B
AUM Growth
–
Cap. Flow
+$1.06B
Cap. Flow
% of AUM
86.51%
Top 10 Holdings %
Top 10 Hldgs %
94.5%
Holding
1,884
New
1,883
Increased
–
Reduced
–
Closed
–
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Royalty Pharma
RPRX
|
+$911M |
| 2 |
ADC Therapeutics
ADCT
|
+$55.1M |
| 3 |
KYNB
Kyntra Bio
KYNB
|
+$25.5M |
| 4 |
ITCI
Intra-Cellular Therapies Inc.
ITCI
|
+$5.96M |
| 5 |
Kroger
KR
|
+$366K |
Top Sells
No sells this quarter
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 95.04% |
| 2 | Technology | 0.89% |
| 3 | Consumer Discretionary | 0.79% |
| 4 | Industrials | 0.61% |
| 5 | Consumer Staples | 0.61% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1101
Dick's Sporting Goods
DKS
$17.5B
| $12K | ﹤0.01% |
+216
| New | +$12.3K |
|
1102
DXP Enterprises
DXPE
$2.43B
| $12K | ﹤0.01% |
+547
| New | +$11.1K |
|
1103
Exponent
EXPO
$3.24B
| $12K | ﹤0.01% |
+130
| New | +$10.4K |
|
1104
Five Below
FIVE
$12B
| $12K | ﹤0.01% |
+69
| New | +$10.2K |
|
1105
Genworth Financial
GNW
$3.76B
| $12K | ﹤0.01% |
+3,047
| New | +$12.5K |
|
1106
Hain Celestial
HAIN
$45M
| $12K | ﹤0.01% |
+292
| New | +$10.6K |
|
1107
Helmerich & Payne
HP
$3.45B
| $12K | ﹤0.01% |
+501
| New | +$9.71K |
|
1108
iShares Expanded Tech-Software Sector ETF
IGV
$12.7B
| $12K | ﹤0.01% |
+180
| New | +$11.9K |
|
1109
Ingredion
INGR
$6.27B
| $12K | ﹤0.01% |
+152
| New | +$11.7K |
|
1110
iShares Russell Top 200 Growth ETF
IWY
$15.9B
| $12K | ﹤0.01% |
+92
| New | +$11.6K |
|
1111
JetBlue
JBLU
$2.28B
| $12K | ﹤0.01% |
+799
| New | +$11K |
|
1112
St. Joe Company
JOE
$3.54B
| $12K | ﹤0.01% |
+278
| New | +$8.85K |
|
1113
Kirby Corp
KEX
$7.01B
| $12K | ﹤0.01% |
+223
| New | +$10.2K |
|
1114
Vanguard Morningstar Mega Cap Growth ETF
MGK
$32.5B
| $12K | ﹤0.01% |
+300
| New | +$11.6K |
|
1115
Merit Medical Systems
MMSI
$5.08B
| $12K | ﹤0.01% |
+224
| New | +$11.6K |
|
1116
Matador Resources
MTDR
$6.2B
| $12K | ﹤0.01% |
+1,014
| New | +$9.91K |
|
1117
New York Times
NYT
$12.1B
| $12K | ﹤0.01% |
+228
| New | +$10.1K |
|
1118
Ollie's Bargain Outlet
OLLI
$4.44B
| $12K | ﹤0.01% |
+147
| New | +$12.8K |
|
|
ACH
1119
Accendra Health
ACH
$237M
| $12K | ﹤0.01% |
+453
| New | +$11.7K |
|
1120
Post Holdings
POST
$4.14B
| $12K | ﹤0.01% |
+177
| New | +$10.9K |
|
1121
Pilgrim's Pride
PPC
$6.51B
| $12K | ﹤0.01% |
+593
| New | +$10.7K |
|
1122
Scansource
SCSC
$1.15B
| $12K | ﹤0.01% |
+459
| New | +$11K |
|
1123
SM Energy
SM
$7.8B
| $12K | ﹤0.01% |
+2,027
| New | +$6.83K |
|
1124
Talos Energy
TALO
$2.53B
| $12K | ﹤0.01% |
+1,465
| New | +$11.4K |
|
1125
Interface
TILE
$1.99B
| $12K | ﹤0.01% |
+1,123
| New | +$8.98K |
|
Similar funds
MVG
NCM
FFGIM
PIM
HFG
SWM
ICM
SM
Vantage Consulting Group's Q4 2020 Portfolio in Review
Q4 2020 is the first quarter with a 13F filing on record for Vantage Consulting Group, which disclosed 1,884 positions worth $1.23B. Its ten largest holdings account for 94% of the portfolio.
Its largest position is Royalty Pharma: 21,477,282 shares worth $1.07B.
By sector, the portfolio is most concentrated in Healthcare at 95% of assets, followed by Technology and Consumer Discretionary.
- Vantage Consulting Group's largest Q4 2020 buy was Royalty Pharma: 21,477,282 shares worth $1.07B.
- Vantage Consulting Group's ten largest holdings make up 94% of its $1.23B portfolio in Q4 2020.
- Vantage Consulting Group disclosed 1,884 positions in Q4 2020, its first 13F filing on record.
Based on Vantage Consulting Group's 13F filing for Q4 2020, filed 12 Feb 2021.